10.00 – 10.40
Session I
MODERATORS: Joanna Kwiatkowska (Gdańsk), Jacek Kusa (Wrocław/Katowice), Grzegorz Kopeć (Kraków)
Welcome
JOANNA KWIATKOWSKA (Gdańsk)
Presentation speakers and topics session
JACEK KUSA (Wrocław/Katowice)
Where are we today? Multicenter Polish Pediatrics PH Registry (BNP-PL children)
JOANNA KWIATKOWSKA(Gdańsk)
National Health Fund Criteria for PAH treatment
EWA MROCZEK (Wrocław)
Sotatercept – a new treatment option in PAH for adults
PROF. GRZEGORZ KOPEĆ (Kraków)
Discussion
10.40 – 11.25
Session II
MODERATORS: Jacek Kusa (Wrocław/Katowice), Grzegorz Kopeć (Kraków)
Diagnostic approach in pediatric PH and its impact on pharmacotheraphy
in different PH Groups (focus mainly on Group 2 in children and Group 5 in children)
- Which prostanoids for whom and when?
- Which one is better and why?
- How should we escalate the dose?
- What is the target of treatment in 2023?
PROF. ROLF BERGER (Groningen)
12:00 – 12:15
COFFEE BREAK
12.15 – 12.45
Session III
MODERATORS: Rafał Surmacz (Poznań), Jarosław Meyer-Szary (Gdańsk)
Fontan circulation and target PH theraphy
OLIVIER MIERA (Berlin)
13.00 – 13.40
Session IV
MODERATORS: Paweł Banaszak (Zabrze)
LTX in children in EU and in Poland.
Pharmacotheraphy as a by-pass to LTX
PROF. ROLF BERGER / PROF. JACEK WOJARSKI (Gdańsk)
13.00 – 13.40
INTRODUCTION TO SESSION V
ViewPoint 6 - Transfer ultrasound data into clinical excellence
INŻ. BŁAŻEJ KOWALSKI, GE
15.00 – 17.00
Session V
MODERATORS: Małgorzata Żuk (Warszawa), Rolf Berger (Groningen), Oliwier Miera (Berlin)
Difficult questions/cases – workshop
1. Pulmonary Hypertension Due to Left Heart Disease
- the evidence base for pharmacotherapy
GDAŃSK
2. Eisenmenger Syndrome due to aorto-pulmonary window
with sever aortic stenosis
ŁÓDŹ
3. Boy with IPAH 2 with stented PDA on double target therapy
ŁÓDŹ
4. Pulmonary hypertension in a patient with transposition
of the great arteries
WROCŁAW
5. Young patient with IPAH with optimal therapy?
POZNAŃ
Closing remarks
JOANNA KWIATKOWSKA (Gdańsk)
The conference is aimed at persons authorized to issue prescriptions or persons trading in medicinal products - legal basis Act of September 6, 2001. Pharmaceutical law ( Journal of Laws of 2018, No. 234, item 1570 )
